| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $51K | -16.4% | -86.0% |
| SG&A Expense | $1.8M | +145.1% | +518.5% |
| Operating Income | -$1.8M | -132.5% | -83.2% |
| Interest Expense | $457 | -74.8% | -56.4% |
| Net Income | -$2.0M | -155.3% | -100.8% |
| EPS (Basic) | -$0.33 | -13.8% | +25.0% |
| EPS (Diluted) | -$0.33 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.4M | +449.0% | +221.7% |
| Total Assets | $5.4M | +357.2% | +220.4% |
| Current Liabilities | $521K | -2.9% | +58.5% |
| Stockholders' Equity | $4.9M | +654.0% | +259.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | — |
| Investing Cash Flow | -$2.6M | — | — |
| Financing Cash Flow | $6.5M | — | — |
| -13.8% |
| +25.0% |